Democratic Republic of Congo vs Malta: Access to anti-retroviral drugs, male (%)
Democratic Republic of Congo
75.0%
in 2024
Malta
74.0%
in 2024
Democratic Republic of Congo rank
55th
Malta rank
58th
Access to anti-retroviral drugs, male (%) over time
- Democratic Republic of Congo
- Malta
How they compare
Democratic Republic of Congo currently reports 75.0% against 74.0% in Malta, a difference of 1.0%.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was Malta ahead.
Democratic Republic of Congo ranks 55th and Malta ranks 58th of 141 countries.
Across the 3 decades both report, Democratic Republic of Congo averaged higher in 1 and Malta in 2.
Head to head by decade
| Decade | Democratic Republic of Congo | Malta | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.9% | 21.6% | 19.7% | Malta |
| 2010s | 19.5% | 45.0% | 25.5% | Malta |
| 2020s | 68.0% | 65.4% | 2.6% | Democratic Republic of Congo |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Democratic Republic of Congo or Malta?
- Democratic Republic of Congo, at 75.0% against 74.0% in Malta as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Democratic Republic of Congo and Malta?
- 1.0%, with Democratic Republic of Congo ahead.
- How many years of comparable data are there for Democratic Republic of Congo and Malta?
- 25 years are reported by both, from 2000 to 2024.
- How do Democratic Republic of Congo and Malta rank globally for access to anti-retroviral drugs, male?
- Democratic Republic of Congo ranks 55th and Malta ranks 58th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.